H.O. Oloyede et al. / Journal of Molecular Structure 1199 (2020) 127030
3
26.40%. Found: C, 67.79; H, 5.69; N, 26.38%.
J ¼ 8.3 Hz, 2H), 7.36 (t, J ¼ 7.6 Hz, 2H), 7.17 (s, 2H), 7.12 (t, J ¼ 7.6 Hz,
2H), 4.31 (hept, J ¼ 6.7 Hz, 4H), 2.90 (dt, J ¼ 13.8, 6.9 Hz, 2H), 1.25 (d,
J ¼ 6.9 Hz, 12H), 1.21 (d, J ¼ 6.7 Hz, 24H). 13C NMR (101 MHz, d6-
(E)-N,N'-(diazene-1,2-diylbis(2,1-phenylene))dimethane-
sulfonamide (L1): Methanesulfonyl chloride (1.37 mL, 17.67 mmol)
was added dropwise to a solution of DAB (1.25 g, 5.89 mmol) in
20 mL of pyridine at 0 ꢁC while stirring in a 50 mL round-bottomed
flask. The reaction mixture was then stirred at room temperature
for 12 h and subsequently concentrated under reduced pressure.
Ethanol (5 mL) was added to the residue, filtered and washed with
chloroform (5 mL) followed by ethanol (10 mL). L1 was obtained as
a yellow powder. Yield (1.83 g, 84%). Mp ¼ 264 ꢁC. Selected IR data
(ATR cmꢀ1): v 3458m, 3360m, 3057w, 3025w, 1598s, 1570s, 1476m,
1304s, 1217s, 1137s, 739vs. 1H NMR (400 MHz, DMSO‑d6): dppm 9.83
(s, 2H), 8.00 (d, J ¼ 8.0 Hz, 2H), 7.60 (dt, J ¼ 15.2, 7.7 Hz, 4H), 7.35 (t,
CDCl3):
d 153.53, 150.66, 137.89, 135.44, 133.05, 132.28, 124.13,
123.10, 122.93, 117.68, 34.12, 29.81, 25.61, 24.74, 23.47. MS (EI) m/z
744 (Mþ, 40%): 477, 371, 267. Anal. Calc. for C42H56N4O4S2: C, 66.90;
H, 7.62; N, 7.43; S, 8.50%. Found: C, 67.16; H, 7.53; N, 7.50; S, 8.32%.
2.3. Syntheses of palladium complexes
Pd.L1.w: L1 (30 mg, 0.08 mmol) and palladium(II) acetate
(18 mg, 0.08 mmol) were added together in chloroform (2 mL). The
clear solution was then precipitated by addition of n-hexane to
obtain Pd.L1.w as brown powder. Yield (20 mg, 51%). Mp ¼ 299 ꢁC.
Selected IR data (ATR cmꢀ1): v 3380w (br), 3043w, 1590m, 1572w,
1543w, 1475m, 1292vs, 1220vs, 1162m, 1119vs, 954vs, 844vs, 761vs,
627vs. MS (EI) m/z 490 (Mþ, 7%), 494 (Mþ ꢀ H2O þ Na), (473
(Mþ ꢀ H2O, 20%), 391 (Lþ þ Na). Anal. Calc. for C14H16N4O5PdS2.
H2O.½CH3COOH: C, 33.43; H, 3.74; N, 10.40; S, 11.90%. Found: C,
33.26; H, 3.34; N, 10.17; S, 11.64%.
Pd.L1.acn: L1 (30 mg, 0.08 mmol) and palladium(II) acetate
(18 mg, 0.08 mmol) were added together and dissolved in aceto-
nitrile (1 mL) layered with diethylether (1 mL). The clear solution
was allowed to stand for 1 day. The microcrystalline product was
filtered, washed with acetonitrile and air-dried to give Pd.L1.acn as
a purple solid. Yield (0.03 g, 74%), Mp ¼ 293e295 ꢁC.Selected IR
data (ATR cmꢀ1):v 2347w, 2309w, 1593m, 1570m, 1453m, 1292vs,
1118vs, 952vs, 837vs,746vs, 626vs. MS (EI) m/z 473 (Mþ eCH3CN,
20%): 392, 314, 288, 212, 176, 105, 79, 41, 28. Anal. Calc. for
J ¼ 7.2 Hz, 2H), 3.08 (s, 6H). 13C NMR (101 MHz, DMSO‑d6):
d 143.97,
137.27, 133.22, 125.57, 124.19, 118.02, 55.36. MS (EI) m/z 368 (Mþ,
45%): 289, 210, 198, 181, 154, 108, 91, 79, 65, 51. Anal. Calc. for
C
14H16N4O4S2: C, 45.64; H, 4.38; N, 15.21; S, 17.41%. Found: C, 45.58;
H, 4.42; N, 14.96; S, 17.76%.
(E)-N,N'-(diazene-1,2-diylbis(2,1-phenylene))bis(4-
methylbenzenesulfonamide) (L2): DAB (1.25 g, 5.89 mmol) and p-
toluenesulfonyl chloride (3.37 g, 17.67 mmol) were mixed in 20 mL
of pyridine inside a 50 mL round-bottom flask while stirring at
room temperature. The reaction mixture was then refluxed at
100 ꢁC for 12 h. The product was concentrated under reduced
pressure. Ethanol (5 mL) was added to the residue which was
filtered and then washed with chloroform (5 mL) and ethanol
(10 mL) to give L2 as an orange powder. Yield (2.82 g, 92%).
Mp ¼ 272 ꢁC. Selected IR data (ATR cmꢀ1): v 3265m, 3251m, 3085w,
1594s, 1481s, 1386s, 1332s, 1161vs, 1089vs, 904vs, 654vs. 1H NMR
(400 MHz, DMSO‑d6): dppm 10.17 (s, 2H), 7.67e7.54 (m, 6H), 7.51 (d,
J ¼ 3.9 Hz, 4H), 7.26 (dt, J ¼ 8.3, 4.2 Hz, 2H), 7.14 (d, J ¼ 8.0 Hz, 4H),
2.18 (s, 6H).13C NMR (101 MHz, DMSO‑d6): dppm 144.19, 143.59,
137.44, 136.57, 132.85, 129.86, 127.06, 125.72, 125.09, 117.75, 21.28.
MS (EI) m/z 520 (Mþ, 98%): 365, 347, 210. Anal. Calc. for
C16H17N5O4PdS2C, 37.40; H, 3.33; N, 13.63; S, 12.48%. Found: C,
37.79; H, 3.27; N, 13.60; S, 12.52%.
Pd.L1.py: L1 (30 mg, 0.08 mmol), palladium(II) acetate (18 mg,
0.08 mmol) and pyridine (0.1 mL) were added together in aceto-
nitrile (2 mL). Pd.L1.py was obtained as purple powder the
following day. Yield (0.04 g, 90%). Mp ¼ 220 ꢁC. Selected IR data
(ATR cmꢀ1):v 2945w, 2877w, 1590m, 1451s, 1295vs, 1239m, 1125vs,
945vs, 856vs, 753vs, 695vs. MS (EI) m/z 474 (Mþ -Py, 20%), 368 (Lþ,
15%), 289, 210, 108, 79 (Pyþ), 52, 28. Anal. Calc. for
C
26H24N4O4S2 C, 59.98; H, 4.65; N, 10.76; S, 12.32%. Found: C, 60.13;
H, 4.66; N, 10.79; S, 12.45%.
(E)-N-(2-((2-aminophenyl)diazenyl)phenyl)-2,4,6-
triisopropylbenzenesulfonamide (L3) and (E)-N,N'-(diazene-1,2-
diylbis(2,1-phenylene))bis(2,4,6-
C19H19N5O4PdS2.1.3CH3CN: C, 42.86; H, 3.81; N, 14.58; S, 10.59%.
triisopropylbenzenesulfonamide) (L4): 2, 4, 6-triiso-pro-
pylbenzenesulfonyl chloride, (3.57 g, 11.78 mmol) was added to a
pyridine (20 mL) solution of DAB (1.25 g, 5.89 mmol) in a 50 mL
round-bottom flask. The reaction mixture was refluxed at 120 ꢁC for
12 h. The mixture was concentrated under reduced pressure to
obtain the crude product. Purification was carried out on column
chromatography with silica gel, n-hexane/THF (7:3) and later
chloroform/methanol (1:1). L3 was obtained as a red powder while
yellow powder of L4 was eluted as the second product.
Found: C, 43.27; H, 3.65; N, 14.21; S, 10.45%.
Pd.L2: L2 (30 mg, 0.06 mmol) and palladium(II) acetate (13 mg,
0.06 mmol) were added together and dissolved in chloroform
(1 mL). The clear solution was layered with n-hexane to give Pd.L2
as purple crystals. Single crystal suitable for X-ray measurement
was obtained from the mother liquor. Yield (0.02 g, 54%).
Mp ¼ 325e327 ꢁC.Selected IR data (ATR cmꢀ1): v 1690m, 1590m,
L3: Yield (1.20 g, 28%). Mp ¼ 249 ꢁC. Selected IR data (ATR cmꢀ1):
v 3449m, 3290w, 2959s, 2867w, 1617s, 1599s, 1556s, 1482s, 1307s,
1226s, 1149vs, 1039vs, 908s, 753 vs, 651vs.1H NMR (400 MHz,
DMSO‑d6): dppm 10.28 (s, 1H), 7.82e7.71 (m, 1H), 7.62e7.47 (m, 1H),
7.34 (t, J ¼ 7.1 Hz, 1H), 7.30e7.23 (m, 2H), 7.19 (s, 3H), 6.89 (s, 2H),
6.85 (d, J ¼ 8.1 Hz, 1H), 6.58 (t, J ¼ 7.2 Hz, 1H), 4.06 (dt, J ¼ 13.3,
6.6 Hz, 2H), 2.99e2.75 (m, 1H), 1.17 (d, J ¼ 6.9 Hz, 6H), 1.08 (d,
J ¼ 6.7 Hz, 12H). 13C NMR (101 MHz, DMSO‑d6):
d 152.90, 151.45,
150.28, 146.11, 145.24, 137.58, 136.53, 134.47, 134.14, 133.38, 132.48,
130.74, 126.07, 125.19, 124.27, 124.18, 118.97, 117.41, 115.77, 79.64,
33.72, 29.65, 25.03, 23.80. MS (EI) m/z 478 (Mþ, 60%): 371, 357, 293,
211, 183, 120, 91. Anal. Calc. for C27H34N4O2S2: C, 67.75; H, 7.16; N,
11.71; S, 6.70%. Found: C, 67.79; H, 7.11; N, 11.72; S, 6.34%.
(L4): Yield (1.45 g, 33%). Mp ¼ 158 ꢁC. Selected IR data (ATR
cmꢀ1): v 3290s, 2960s, 2871m, 1591m, 1558m, 1479s, 1378s, 1281
vs, 1165vs, 1150vs, 1039s, 906vs, 825s, 665vs. 1H NMR (400 MHz,
d6-CDCl3): dppm 10.07 (s, 2H), 7.63 (d, J ¼ 7.8 Hz, 2H), 7.47 (d,
Fig. 1. Ortep plot of ligand L1 with thermal ellipsoids drawn at the 40% probability
level. Protons have been omitted for clarity.